Atlas Venture

Type

Venture Capital

Status

Active

Location

Cambridge, United States

Total investments

587

Average round size

21M

Portfolio companies

305

Rounds per year

13.34

Lead investments

81

Follow on index

0.48

Exits

156

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareAnalyticsMobileHealth CareEnterprise SoftwareMedicalPharmaceuticalTherapeutics

Summary

Atlas Venture is the famous VC, which was founded in 1980. The leading representative office of defined VC is situated in the Cambridge. The fund was located in North America if to be more exact in United States.

The fund was created by Michiel de Haan. Besides them, we counted 6 critical employees of this fund in our database.

The average startup value when the investment from Atlas Venture is 10-50 millions dollars. Considering the real fund results, this VC is 8 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Atlas Venture works on 3 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 13-24 investment rounds annually.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Atlas Venture, startups are often financed by Techstars Boston Accelerator, Highland Capital Partners, Bessemer Venture Partners. The meaningful sponsors for the fund in investment in the same round are Sofinnova Investments, Partners Innovation Fund, Flagship Pioneering. In the next rounds fund is usually obtained by Venrock, Silicon Valley Bank, SV Health Investors.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Software, Medical. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Isilon Systems, DraftKings, Carbon Black

Show more

Investor highlights

Industry focus
Biotech/Life Sciences
Stage focus
GeneralistSeed
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 450000000
Fund raised date
2022-03-03

Analytics

Total investments
587
Lead investments
81
Exits
156
Rounds per year
13.34
Follow on index
0.48
Investments by industry
  • Biotechnology (212)
  • Health Care (143)
  • Therapeutics (123)
  • Software (119)
  • Medical (83)
  • Show 244 more
Investments by region
  • United States (462)
  • United Kingdom (59)
  • Germany (18)
  • France (8)
  • Italy (3)
  • Show 12 more
Peak activity year
2014
Number of Unicorns
8
Number of Decacorns
8
Number of Minotaurs
7

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
124M
Group Appearance index
0.95
Avg. company exit year
8
Avg. multiplicator
1.79
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Chroma Medicine 01 Jan 2020 Biotechnology, Medical, Therapeutics Seed United States, Massachusetts, Cambridge
Pheon Therapeutics 21 May 2024 Biotechnology, Medical, Life Science, Therapeutics Early Stage Venture 120M England, London, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.